SCHEMBL24528818

SCHEMBL24528818

CC(=O)C1CCN(C(=O)Cn2cc(C)cn2)CC1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALPI P09923 1/20 0.41
ALPG P10696 1/20 0.41
PLAA Q9Y263 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
CREBBP Q92793 2/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP46A1 Q9Y6A2 2/20 0.37
GABRD O14764 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRB2 P47870 1/20 0.36
GABRA4 P48169 1/20 0.36
CCNC P24863 1/20 0.36
CDK8 P49336 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
KHK P50053 1/20 0.36
RIPK1 Q13546 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27292690 0.86 SMN1; SMN2 (0.54) ALPIALPGPLAASMN1; SMN2ALDH1A1
SCHEMBL17382013 0.83 ALPI (0.47) ALPIALPGPLAASMN1; SMN2CCNC
SCHEMBL12121175 0.83 ALPI (0.47) ALPIALPGPLAASMN1; SMN2ALDH1A1
SCHEMBL19226570 0.83 P2RY12 (0.41) ALPIALPGPLAASMN1; SMN2ALDH1A1
SCHEMBL17340938 0.81 ALPI (0.37) ALPIALPGPLAASMN1; SMN2ALDH1A1
SCHEMBL19014559 0.80 CCNC (0.51) ALPIALPGPLAASMN1; SMN2ALDH1A1
SCHEMBL24528819 0.80 LMNA (0.39) ALPIALPGPLAASMN1; SMN2ALDH1A1
SCHEMBL13102474 0.79 POLB (0.50) ALPIALPGPLAASMN1; SMN2ALDH1A1
SCHEMBL13103451 0.79 SMN1; SMN2 (0.51) ALPIALPGPLAASMN1; SMN2ALDH1A1
SCHEMBL21078192 0.77 THRB (0.52) SMN1; SMN2ALDH1A1CCNCCDK8LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023242598-A1 BIFUNCTIONAL MOLECULES FOR TARGETED PROTEIN DEGRADATION AMPHISTA THERAPEUTICS LIMITED (GB) 2023-12-21 WO disclosed
WO-2022129925-A1 NOVEL BIFUNCTIONAL MOLECULES FOR TARGETED PROTEIN DEGRADATION AMPHISTA THERAPEUTICS LIMITED (GB) 2022-06-23 WO disclosed